Literature DB >> 18000149

HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty.

Loic Desquilbet1, Lisa P Jacobson, Linda P Fried, John P Phair, Beth D Jamieson, Marcy Holloway, Joseph B Margolick.   

Abstract

BACKGROUND: Older healthy and HIV-infected adults exhibit physiological similarities. Frailty is a clinical syndrome associated with aging that identifies a subset of older adults at high risk of mortality and other outcomes. We investigated whether HIV infection increases the prevalence of a frailty-related phenotype (FRP) that approximates a clinical definition of frailty.
METHODS: We first defined the FRP and assessed its prevalence among HIV-uninfected men followed in the Multicenter AIDS Cohort Study (MACS) between 1994 and 2004. Using repeated measurements logistic regression models, we then assessed the association between FRP and HIV infection before the era of highly active antiretroviral therapies, adjusting for covariates among HIV-uninfected (N = 1905) and incident HIV cases (N = 245).
RESULTS: HIV infection was strongly associated with FRP prevalence. Compared to HIV-uninfected men of similar age, ethnicity and education, HIV-infected men were more likely to have the FRP for all durations of infection: for < or =4 years, the adjusted odds ratio (OR) was 3.38, with 95% confidence interval (CI), 1.25-9.11, and for 4.01-8 years and 8.01-12 years the corresponding figures were (OR = 12.95, 95% CI, 6.60-25.40) and (OR = 14.68, 95% CI, 7.60-28.35), respectively. The FRP prevalence for 55-year-old men infected with HIV for < or =4 years (3.4%; 95% CI, 1.3-8.6) was similar to that of uninfected men > or =65 years old (3.4%; 95% CI, 1.5-7.6).
CONCLUSION: In this cohort, HIV infection was associated with an earlier occurrence of a phenotype that resembles the phenotype of frailty in older adults without HIV infection. Studies of frailty in the setting of HIV infection may help to clarify the biological mechanism of frailty.

Entities:  

Mesh:

Year:  2007        PMID: 18000149     DOI: 10.1093/gerona/62.11.1279

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  183 in total

1.  Independent effects of HIV, aging, and HAART on brain volumetric measures.

Authors:  Beau M Ances; Mario Ortega; Florin Vaida; Jodi Heaps; Robert Paul
Journal:  J Acquir Immune Defic Syndr       Date:  2012-04-15       Impact factor: 3.731

Review 2.  HIV and inflammation: mechanisms and consequences.

Authors:  Peter W Hunt
Journal:  Curr HIV/AIDS Rep       Date:  2012-06       Impact factor: 5.071

3.  HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group.

Authors:  Kevin P High; Mark Brennan-Ing; David B Clifford; Mardge H Cohen; Judith Currier; Steven G Deeks; Sherry Deren; Rita B Effros; Kelly Gebo; Jörg J Goronzy; Amy C Justice; Alan Landay; Jules Levin; Paolo G Miotti; Robert J Munk; Heidi Nass; Charles R Rinaldo; Michael G Shlipak; Russell Tracy; Victor Valcour; David E Vance; Jeremy D Walston; Paul Volberding
Journal:  J Acquir Immune Defic Syndr       Date:  2012-07-01       Impact factor: 3.731

Review 4.  A challenge for the future: aging and HIV infection.

Authors:  Tammy M Rickabaugh; Beth D Jamieson
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

5.  Vitamin D deficiency in HIV-infected postmenopausal Hispanic and African-American women.

Authors:  E M Stein; M T Yin; D J McMahon; A Shu; C A Zhang; D C Ferris; I Colon; J F Dobkin; S M Hammer; E Shane
Journal:  Osteoporos Int       Date:  2010-06-29       Impact factor: 4.507

6.  Role of CD8 T Cell Replicative Senescence in Human Aging and in HIV-mediated Immunosenescence.

Authors:  Jeffrey N Dock; Rita B Effros
Journal:  Aging Dis       Date:  2011-10       Impact factor: 6.745

7.  Frailty, Inflammation, and Mortality Among Persons Aging With HIV Infection and Injection Drug Use.

Authors:  Damani A Piggott; Ravi Varadhan; Shruti H Mehta; Todd T Brown; Huifen Li; Jeremy D Walston; Sean X Leng; Gregory D Kirk
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-09-18       Impact factor: 6.053

8.  Relationship between poor physical function, inflammatory markers, and comorbidities in HIV-infected women on antiretroviral therapy.

Authors:  Amy S Baranoski; Ariana Harris; Daniel Michaels; Renee Miciek; Thomas Storer; Paola Sebastiani; Monty Montano
Journal:  J Womens Health (Larchmt)       Date:  2013-11-12       Impact factor: 2.681

9.  The relationship of physical performance with HIV disease and mortality.

Authors:  Meredith Greene; Kenneth Covinsky; Jacquie Astemborski; Damani A Piggott; Todd Brown; Sean Leng; Noya Galai; Shruti H Mehta; Jack Guralnik; Kushang V Patel; Gregory D Kirk
Journal:  AIDS       Date:  2014-11-28       Impact factor: 4.177

10.  Long-term body composition changes in antiretroviral-treated HIV-infected individuals.

Authors:  Philip M Grant; Douglas Kitch; Grace A McComsey; Ann C Collier; Benedetta Bartali; Susan L Koletar; Kristine M Erlandson; Jordan E Lake; Michael T Yin; Kathy Melbourne; Belinda Ha; Todd T Brown
Journal:  AIDS       Date:  2016-11-28       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.